ESH/LinkedIn
Mar 3, 2026, 15:16
Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH
European School of Haematology (ESH) shared a post on LinkedIn:
“Programme Highlight of ESHMM 2026!
Debate 3 – Transplant vs CAR T cells.
Moderated by Martin Kaiser with Mohamad Mohty and Robert Orlowski (with audience voting)
Less than a month to go before the conference begins!
Secure your spot today — Register now and Join us on March 26-28, 2026 in Stockholm, Sweden.
8th Translational Research Conference on Multiple Myeloma.
Conference Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch”
Stay updated with Hemostasis Today.
-
Apr 21, 2026, 11:45Heghine Khachatryan: Heavy Menstrual Bleeding in Women with Bleeding Disorders – Key Insights from WFH 2026
-
Apr 21, 2026, 11:42Xiaoying Chen: Rethinking Thrombectomy in Large-Core Stroke – Insights from LASTE Analysis
-
Apr 21, 2026, 11:40Emna HAMMAMI: Unpublished Dutch Data on IPFD Management Shared at EHA-SWG Meeting
-
Apr 21, 2026, 11:34Are Platelets Really Just Clotting Cells or Immune Orchestrators? – RPTH Journal
-
Apr 21, 2026, 11:22Leonard Valentino: The Importance of Early Diagnosis and Treatment of Hemophilia in Women and Girls – WFH2026
-
Apr 21, 2026, 11:20Shehab Mohamed: Thrombotic Complications in APL Are Not Rare and May Be Underrecognized
-
Apr 21, 2026, 09:29Wolfgang Miesbach: Can Gene Therapy Redefine Aging and Healthy Longevity?
-
Apr 21, 2026, 09:15Jim Hoffman: Targeting NETosis and Microclotting to Restore Immune and Hemostatic Balance
-
Apr 21, 2026, 09:00Amer Zeidan: Can Early Blood Count Changes Predict Imetelstat Response in Lower Risk MDS?